14 results on '"Novartis Pharma AG -- Reports"'
Search Results
2. Studies from King Fahad Medical City Have Provided New Data on Psoriatic Arthritis (Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting)
3. Researchers from University of California San Francisco (UCSF) Report Details of New Studies and Findings in the Area of Prostate Cancer (Single-dose 177lu-psma-617 Followed By Maintenance Pembrolizumab In Patients With Metastatic Castration- ...)
4. Data on Asthma Described by Researchers at Guangzhou Medical University (Efficacy and Safety of Omalizumab In Patients With Moderate-to-severe Asthma: an Analytic Comparison of Data From Randomized Controlled Trials Between Chinese and ...)
5. Studies from University Hospital Munster in the Area of Juvenile Rheumatoid Arthritis Described (A Dysregulated Interleukin-18-interferon-gamma-cxcl9 Axis Impacts Treatment Response To Canakinumab In Systemic Juvenile Idiopathic Arthritis)
6. Researchers at University of Iceland Release New Data on Psoriasis (Secukinumab Demonstrates Efficacy, Safety, and Tolerability Upon Administration By 2 Ml Autoinjector In Adult Patients With Plaque Psoriasis: 52-week Results From Mature, a ...)
7. Data on Allergies Reported by Researchers at Genentech Inc. (Omalizumab Response In Patients With Asthma By Number and Type of Allergen)
8. Study Findings from General Hospital of the Chinese People's Liberation Army Provide New Insights into Ankylosing Spondylitis (Secukinumab Provided Significant and Sustained Improvement In the Signs and Symptoms of Ankylosing Spondylitis: ...)
9. New Findings from University Medical Center Hamburg-Eppendorf in the Area of Psoriasis Reported (Secukinumab Treatment Leads To Normalization of Quality of Life and Disease Symptoms In Psoriasis Patients With or Without Prior Systemic Psoriasis ...)
10. New Psoriasis Study Findings Recently Were Reported by Researchers at Novartis Pharmaceuticals K.K. (Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab)
11. Findings from University Medical Centre Hamburg-Eppendorf (UKE) Has Provided New Data on Psoriasis (Real-world Evidence of Secukinumab In Psoriasis Treatment - a Meta-analysis of 43 Studies)
12. Recent Findings from Icahn School of Medicine at Mount Sinai Provides New Insights into Psoriasis (Sustained Efficacy of Secukinumab In Patients With Moderate-to-severe Palmoplantar Psoriasis: 2 Center Dot 5-year Results From Gesture, a ...)
13. Studies from Rockefeller University Describe New Findings in Psoriasis (Il-17a Inhibition By Secukinumab Induces Early Clinical, Histopathologic, and Molecular Resolution of Psoriasis)
14. New Psoriasis Study Findings Have Been Reported by Researchers at Novartis (Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3a4 Substrate Midazolam In Patients With Moderate To Severe Psoriasis)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.